The Journal of Bone and Joint Surgery (American). 2009;91:1791-1805.
doi:10.2106/JBJS.I.00096
© 2009 The Journal of Bone and Joint Surgery, Inc.
Department of Justice Investigation of Orthopaedic Industry*
William L. Healy, MD1 and
Richard N. Peterson, JD2
1 Department of Orthopaedic Surgery, Lahey Clinic, 41 Mall Road, Burlington, MA 01805
2 6300 North River Road, Rosemont, IL 60018
Investigation performed at the Department of Orthopaedic Surgery, Lahey Clinic Medical Center, Burlington, Massachusetts, and the American Academy of Orthopaedic Surgeons, Rosemont, Illinois
| The first 150 words of the full text of this article appear below. |
 |
Introduction
|
|---|
The U.S. Department of Justice investigation of orthopaedic industry changed the business model of orthopaedics in the United States. Collaboration between orthopaedic companies and orthopaedic surgeons changed, the process of developing new orthopaedic products changed, and industry funding of orthopaedic activities and orthopaedic professional organizations changed. This article reviews the Department of Justice investigation of orthopaedic industry, describes the response of multiple stakeholders, and assesses the impact of the investigation on orthopaedic companies, orthopaedic surgeons, and orthopaedic patients.
 |
Department of Justice Investigation
|
|---|
In March 2005, the U.S. Department of Justice, District of New Jersey, launched a federal investigation into financial relationships between orthopaedic companies and orthopaedic surgeons. The U.S. Attorney for the District of New Jersey, Christopher J. Christie, alleged that orthopaedic companies provided improper financial inducements to orthopaedic surgeons to use their products. The alleged inducements included consulting agreements for questionable work, royalty contracts without transfer of intellectual property, trips to luxury resorts . . . [Full Text of this Article]

CiteULike Connotea Del.icio.us Facebook Technorati Twitter What's this?
|